Investors

Singulex has raised $31 million in two rounds to date.  Our investors include:

OrbiMed Advisors

OrbiMed is one of the world’s largest fully-dedicated healthcare asset management firms, with over $6 billion in assets under management. Since inception of its private equity investment activities in 1993, OrbiMed has successfully made investments in over 70 companies across a wide range of therapeutic categories and stages of development. OrbiMed’s investment team includes over 20 experienced professionals with backgrounds in science, medicine, finance and law.

Fisk Ventures

Fisk Ventures LLC is a private venture capital fund of H. Fisk Johnson, Ph.D., President & CEO of S.C. Johnson & Son.

Advantage Capital Partners

Advantage Capital Partners is an innovative group of venture capital partnerships with more than $950 million under management. Advantage focuses on investing in states and communities that are underserved by traditional sources of risk capital. The firm has built a strong and successful track record of public-private partnerships with state and federal economic development organizations, facilitating the flow of billions of dollars of investment capital into these communities.

Prolog Ventures

Prolog is a venture capital firm specializing in life sciences. The fund has supported more than 20 companies since its launch in 2001. Prolog invests in traditional healthcare opportunities as well as companies in emerging areas such as nutrition, wellness, and green technology.